nodes	percent_of_prediction	percent_of_DWPC	metapath
Isosorbide Mononitrate—CYP3A4—Cytarabine—lymphatic system cancer	0.0548	0.318	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Teniposide—lymphatic system cancer	0.0539	0.313	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0377	0.219	CbGbCtD
Isosorbide Mononitrate—CYP3A4—Vincristine—lymphatic system cancer	0.026	0.151	CbGbCtD
Isosorbide Mononitrate—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00165	0.00199	CcSEcCtD
Isosorbide Mononitrate—Rhinitis—Mitoxantrone—lymphatic system cancer	0.00165	0.00199	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Teniposide—lymphatic system cancer	0.00164	0.00199	CcSEcCtD
Isosorbide Mononitrate—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00164	0.00198	CcSEcCtD
Isosorbide Mononitrate—Flushing—Carmustine—lymphatic system cancer	0.00164	0.00198	CcSEcCtD
Isosorbide Mononitrate—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00163	0.00198	CcSEcCtD
Isosorbide Mononitrate—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00163	0.00197	CcSEcCtD
Isosorbide Mononitrate—Anaemia—Bleomycin—lymphatic system cancer	0.00163	0.00197	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00162	0.00195	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Teniposide—lymphatic system cancer	0.0016	0.00193	CcSEcCtD
Isosorbide Mononitrate—Melaena—Methotrexate—lymphatic system cancer	0.00159	0.00192	CcSEcCtD
Isosorbide Mononitrate—Malaise—Bleomycin—lymphatic system cancer	0.00159	0.00192	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Teniposide—lymphatic system cancer	0.00158	0.00191	CcSEcCtD
Isosorbide Mononitrate—Arrhythmia—Carmustine—lymphatic system cancer	0.00158	0.00191	CcSEcCtD
Isosorbide Mononitrate—Leukopenia—Bleomycin—lymphatic system cancer	0.00158	0.00191	CcSEcCtD
Isosorbide Mononitrate—Cardiac disorder—Vincristine—lymphatic system cancer	0.00157	0.00189	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Fludarabine—lymphatic system cancer	0.00155	0.00187	CcSEcCtD
Isosorbide Mononitrate—Mental disorder—Carmustine—lymphatic system cancer	0.00155	0.00187	CcSEcCtD
Isosorbide Mononitrate—Malnutrition—Carmustine—lymphatic system cancer	0.00154	0.00186	CcSEcCtD
Isosorbide Mononitrate—Cough—Bleomycin—lymphatic system cancer	0.00154	0.00186	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Teniposide—lymphatic system cancer	0.00153	0.00184	CcSEcCtD
Isosorbide Mononitrate—Chest pain—Bleomycin—lymphatic system cancer	0.0015	0.00181	CcSEcCtD
Isosorbide Mononitrate—Myalgia—Bleomycin—lymphatic system cancer	0.0015	0.00181	CcSEcCtD
Isosorbide Mononitrate—Back pain—Carmustine—lymphatic system cancer	0.00149	0.0018	CcSEcCtD
Isosorbide Mononitrate—Discomfort—Bleomycin—lymphatic system cancer	0.00148	0.00179	CcSEcCtD
Isosorbide Mononitrate—Mental disorder—Vincristine—lymphatic system cancer	0.00148	0.00179	CcSEcCtD
Isosorbide Mononitrate—Chills—Mitoxantrone—lymphatic system cancer	0.00147	0.00178	CcSEcCtD
Isosorbide Mononitrate—Urine output increased—Methotrexate—lymphatic system cancer	0.00147	0.00178	CcSEcCtD
Isosorbide Mononitrate—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00147	0.00177	CcSEcCtD
Isosorbide Mononitrate—Confusional state—Bleomycin—lymphatic system cancer	0.00145	0.00175	CcSEcCtD
Isosorbide Mononitrate—Vision blurred—Carmustine—lymphatic system cancer	0.00145	0.00175	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00144	0.00175	CcSEcCtD
Isosorbide Mononitrate—Tremor—Carmustine—lymphatic system cancer	0.00144	0.00174	CcSEcCtD
Isosorbide Mononitrate—Oedema—Bleomycin—lymphatic system cancer	0.00144	0.00174	CcSEcCtD
Isosorbide Mononitrate—Infection—Bleomycin—lymphatic system cancer	0.00143	0.00173	CcSEcCtD
Isosorbide Mononitrate—Anaemia—Carmustine—lymphatic system cancer	0.00142	0.00172	CcSEcCtD
Isosorbide Mononitrate—Back pain—Vincristine—lymphatic system cancer	0.00142	0.00172	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Teniposide—lymphatic system cancer	0.00142	0.00171	CcSEcCtD
Isosorbide Mononitrate—Agitation—Carmustine—lymphatic system cancer	0.00141	0.00171	CcSEcCtD
Isosorbide Mononitrate—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00141	0.0017	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Fludarabine—lymphatic system cancer	0.00141	0.0017	CcSEcCtD
Isosorbide Mononitrate—Rash—Teniposide—lymphatic system cancer	0.00141	0.0017	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Teniposide—lymphatic system cancer	0.00141	0.0017	CcSEcCtD
Isosorbide Mononitrate—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.0014	0.00169	CcSEcCtD
Isosorbide Mononitrate—Headache—Teniposide—lymphatic system cancer	0.0014	0.00169	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Fludarabine—lymphatic system cancer	0.00139	0.00168	CcSEcCtD
Isosorbide Mononitrate—Back pain—Mitoxantrone—lymphatic system cancer	0.00138	0.00167	CcSEcCtD
Isosorbide Mononitrate—Leukopenia—Carmustine—lymphatic system cancer	0.00138	0.00166	CcSEcCtD
Isosorbide Mononitrate—Anorexia—Bleomycin—lymphatic system cancer	0.00137	0.00166	CcSEcCtD
Isosorbide Mononitrate—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.00136	0.00164	CcSEcCtD
Isosorbide Mononitrate—Anaemia—Vincristine—lymphatic system cancer	0.00136	0.00164	CcSEcCtD
Isosorbide Mononitrate—Agitation—Vincristine—lymphatic system cancer	0.00135	0.00163	CcSEcCtD
Isosorbide Mononitrate—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00135	0.00163	CcSEcCtD
Isosorbide Mononitrate—Polyuria—Methotrexate—lymphatic system cancer	0.00135	0.00163	CcSEcCtD
Isosorbide Mononitrate—Hypotension—Bleomycin—lymphatic system cancer	0.00134	0.00162	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Fludarabine—lymphatic system cancer	0.00134	0.00162	CcSEcCtD
Isosorbide Mononitrate—Hypertension—Carmustine—lymphatic system cancer	0.00133	0.0016	CcSEcCtD
Isosorbide Mononitrate—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00133	0.0016	CcSEcCtD
Isosorbide Mononitrate—Nausea—Teniposide—lymphatic system cancer	0.00133	0.0016	CcSEcCtD
Isosorbide Mononitrate—Anaemia—Mitoxantrone—lymphatic system cancer	0.00132	0.0016	CcSEcCtD
Isosorbide Mononitrate—Vertigo—Vincristine—lymphatic system cancer	0.00132	0.00159	CcSEcCtD
Isosorbide Mononitrate—Leukopenia—Vincristine—lymphatic system cancer	0.00131	0.00159	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00131	0.00158	CcSEcCtD
Isosorbide Mononitrate—Myalgia—Carmustine—lymphatic system cancer	0.00131	0.00158	CcSEcCtD
Isosorbide Mononitrate—Chest pain—Carmustine—lymphatic system cancer	0.00131	0.00158	CcSEcCtD
Isosorbide Mononitrate—Anxiety—Carmustine—lymphatic system cancer	0.0013	0.00158	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Bleomycin—lymphatic system cancer	0.00129	0.00156	CcSEcCtD
Isosorbide Mononitrate—Malaise—Mitoxantrone—lymphatic system cancer	0.00129	0.00156	CcSEcCtD
Isosorbide Mononitrate—Dyspnoea—Bleomycin—lymphatic system cancer	0.00128	0.00155	CcSEcCtD
Isosorbide Mononitrate—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00128	0.00155	CcSEcCtD
Isosorbide Mononitrate—Hypertension—Vincristine—lymphatic system cancer	0.00127	0.00153	CcSEcCtD
Isosorbide Mononitrate—Confusional state—Carmustine—lymphatic system cancer	0.00127	0.00153	CcSEcCtD
Isosorbide Mononitrate—Oedema—Carmustine—lymphatic system cancer	0.00126	0.00152	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Bleomycin—lymphatic system cancer	0.00125	0.00151	CcSEcCtD
Isosorbide Mononitrate—Myalgia—Vincristine—lymphatic system cancer	0.00125	0.00151	CcSEcCtD
Isosorbide Mononitrate—Cough—Mitoxantrone—lymphatic system cancer	0.00125	0.00151	CcSEcCtD
Isosorbide Mononitrate—Infection—Carmustine—lymphatic system cancer	0.00125	0.00151	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Fludarabine—lymphatic system cancer	0.00125	0.00151	CcSEcCtD
Isosorbide Mononitrate—Rash—Fludarabine—lymphatic system cancer	0.00124	0.00149	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Fludarabine—lymphatic system cancer	0.00124	0.00149	CcSEcCtD
Isosorbide Mononitrate—Hypertension—Mitoxantrone—lymphatic system cancer	0.00123	0.00149	CcSEcCtD
Isosorbide Mononitrate—Pain—Bleomycin—lymphatic system cancer	0.00123	0.00149	CcSEcCtD
Isosorbide Mononitrate—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00123	0.00148	CcSEcCtD
Isosorbide Mononitrate—Headache—Fludarabine—lymphatic system cancer	0.00123	0.00148	CcSEcCtD
Isosorbide Mononitrate—Tachycardia—Carmustine—lymphatic system cancer	0.00122	0.00148	CcSEcCtD
Isosorbide Mononitrate—Chest pain—Mitoxantrone—lymphatic system cancer	0.00122	0.00147	CcSEcCtD
Isosorbide Mononitrate—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00122	0.00147	CcSEcCtD
Isosorbide Mononitrate—Myalgia—Mitoxantrone—lymphatic system cancer	0.00122	0.00147	CcSEcCtD
Isosorbide Mononitrate—Anxiety—Mitoxantrone—lymphatic system cancer	0.00121	0.00147	CcSEcCtD
Isosorbide Mononitrate—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.00121	0.00146	CcSEcCtD
Isosorbide Mononitrate—Discomfort—Mitoxantrone—lymphatic system cancer	0.0012	0.00145	CcSEcCtD
Isosorbide Mononitrate—Oedema—Vincristine—lymphatic system cancer	0.0012	0.00145	CcSEcCtD
Isosorbide Mononitrate—Anorexia—Carmustine—lymphatic system cancer	0.0012	0.00145	CcSEcCtD
Isosorbide Mononitrate—Infection—Vincristine—lymphatic system cancer	0.00119	0.00144	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00118	0.00143	CcSEcCtD
Isosorbide Mononitrate—Osteoarthritis—Methotrexate—lymphatic system cancer	0.00118	0.00143	CcSEcCtD
Isosorbide Mononitrate—Confusional state—Mitoxantrone—lymphatic system cancer	0.00118	0.00142	CcSEcCtD
Isosorbide Mononitrate—Nervous system disorder—Vincristine—lymphatic system cancer	0.00117	0.00142	CcSEcCtD
Isosorbide Mononitrate—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00117	0.00142	CcSEcCtD
Isosorbide Mononitrate—Hypotension—Carmustine—lymphatic system cancer	0.00117	0.00142	CcSEcCtD
Isosorbide Mononitrate—Oedema—Mitoxantrone—lymphatic system cancer	0.00117	0.00141	CcSEcCtD
Isosorbide Mononitrate—Nausea—Fludarabine—lymphatic system cancer	0.00116	0.00141	CcSEcCtD
Isosorbide Mononitrate—Infection—Mitoxantrone—lymphatic system cancer	0.00116	0.0014	CcSEcCtD
Isosorbide Mononitrate—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00116	0.0014	CcSEcCtD
Isosorbide Mononitrate—Shock—Mitoxantrone—lymphatic system cancer	0.00115	0.00139	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00114	0.00138	CcSEcCtD
Isosorbide Mononitrate—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00114	0.00138	CcSEcCtD
Isosorbide Mononitrate—Anorexia—Vincristine—lymphatic system cancer	0.00114	0.00138	CcSEcCtD
Isosorbide Mononitrate—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00114	0.00138	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Bleomycin—lymphatic system cancer	0.00114	0.00137	CcSEcCtD
Isosorbide Mononitrate—Insomnia—Carmustine—lymphatic system cancer	0.00114	0.00137	CcSEcCtD
Isosorbide Mononitrate—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00113	0.00137	CcSEcCtD
Isosorbide Mononitrate—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00113	0.00136	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Carmustine—lymphatic system cancer	0.00113	0.00136	CcSEcCtD
Isosorbide Mononitrate—Mood swings—Methotrexate—lymphatic system cancer	0.00112	0.00135	CcSEcCtD
Isosorbide Mononitrate—Hypotension—Vincristine—lymphatic system cancer	0.00112	0.00135	CcSEcCtD
Isosorbide Mononitrate—Dyspnoea—Carmustine—lymphatic system cancer	0.00112	0.00135	CcSEcCtD
Isosorbide Mononitrate—Somnolence—Carmustine—lymphatic system cancer	0.00112	0.00135	CcSEcCtD
Isosorbide Mononitrate—Anorexia—Mitoxantrone—lymphatic system cancer	0.00111	0.00134	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00109	0.00132	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Carmustine—lymphatic system cancer	0.00109	0.00132	CcSEcCtD
Isosorbide Mononitrate—Hypotension—Mitoxantrone—lymphatic system cancer	0.00109	0.00132	CcSEcCtD
Isosorbide Mononitrate—Insomnia—Vincristine—lymphatic system cancer	0.00108	0.00131	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00108	0.00131	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Vincristine—lymphatic system cancer	0.00108	0.0013	CcSEcCtD
Isosorbide Mononitrate—Pain—Carmustine—lymphatic system cancer	0.00107	0.0013	CcSEcCtD
Isosorbide Mononitrate—Constipation—Carmustine—lymphatic system cancer	0.00107	0.0013	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00106	0.00128	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00106	0.00128	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00105	0.00127	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Vincristine—lymphatic system cancer	0.00104	0.00126	CcSEcCtD
Isosorbide Mononitrate—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00104	0.00126	CcSEcCtD
Isosorbide Mononitrate—Somnolence—Mitoxantrone—lymphatic system cancer	0.00104	0.00125	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00103	0.00125	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Carmustine—lymphatic system cancer	0.00103	0.00125	CcSEcCtD
Isosorbide Mononitrate—Fatigue—Vincristine—lymphatic system cancer	0.00103	0.00125	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Bleomycin—lymphatic system cancer	0.00103	0.00125	CcSEcCtD
Isosorbide Mononitrate—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00103	0.00124	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00103	0.00124	CcSEcCtD
Isosorbide Mononitrate—Constipation—Vincristine—lymphatic system cancer	0.00102	0.00124	CcSEcCtD
Isosorbide Mononitrate—Pain—Vincristine—lymphatic system cancer	0.00102	0.00124	CcSEcCtD
Isosorbide Mononitrate—Asthma—Methotrexate—lymphatic system cancer	0.00102	0.00124	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Bleomycin—lymphatic system cancer	0.00102	0.00123	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00101	0.00123	CcSEcCtD
Isosorbide Mononitrate—Fatigue—Mitoxantrone—lymphatic system cancer	0.00101	0.00122	CcSEcCtD
Isosorbide Mononitrate—Pain—Mitoxantrone—lymphatic system cancer	0.000998	0.00121	CcSEcCtD
Isosorbide Mononitrate—Constipation—Mitoxantrone—lymphatic system cancer	0.000998	0.00121	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Carmustine—lymphatic system cancer	0.000992	0.0012	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Carmustine—lymphatic system cancer	0.000992	0.0012	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00098	0.00118	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000961	0.00116	CcSEcCtD
Isosorbide Mononitrate—Dysuria—Methotrexate—lymphatic system cancer	0.000956	0.00116	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000954	0.00115	CcSEcCtD
Isosorbide Mononitrate—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00095	0.00115	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Vincristine—lymphatic system cancer	0.000947	0.00114	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Vincristine—lymphatic system cancer	0.000947	0.00114	CcSEcCtD
Isosorbide Mononitrate—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000942	0.00114	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Carmustine—lymphatic system cancer	0.000925	0.00112	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000922	0.00111	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000922	0.00111	CcSEcCtD
Isosorbide Mononitrate—Pneumonia—Methotrexate—lymphatic system cancer	0.000917	0.00111	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Bleomycin—lymphatic system cancer	0.000914	0.0011	CcSEcCtD
Isosorbide Mononitrate—Rash—Bleomycin—lymphatic system cancer	0.000907	0.0011	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Bleomycin—lymphatic system cancer	0.000906	0.00109	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Carmustine—lymphatic system cancer	0.0009	0.00109	CcSEcCtD
Isosorbide Mononitrate—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000886	0.00107	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Vincristine—lymphatic system cancer	0.000883	0.00107	CcSEcCtD
Isosorbide Mononitrate—Sweating—Methotrexate—lymphatic system cancer	0.000874	0.00106	CcSEcCtD
Isosorbide Mononitrate—Haematuria—Methotrexate—lymphatic system cancer	0.000869	0.00105	CcSEcCtD
Isosorbide Mononitrate—Epistaxis—Methotrexate—lymphatic system cancer	0.00086	0.00104	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00086	0.00104	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Vincristine—lymphatic system cancer	0.00086	0.00104	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Carmustine—lymphatic system cancer	0.000859	0.00104	CcSEcCtD
Isosorbide Mononitrate—Nausea—Bleomycin—lymphatic system cancer	0.000854	0.00103	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Mitoxantrone—lymphatic system cancer	0.000837	0.00101	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Carmustine—lymphatic system cancer	0.00083	0.001	CcSEcCtD
Isosorbide Mononitrate—Haemoglobin—Methotrexate—lymphatic system cancer	0.000822	0.000994	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Vincristine—lymphatic system cancer	0.00082	0.000991	CcSEcCtD
Isosorbide Mononitrate—Haemorrhage—Methotrexate—lymphatic system cancer	0.000818	0.000989	CcSEcCtD
Isosorbide Mononitrate—Pharyngitis—Methotrexate—lymphatic system cancer	0.000812	0.000981	CcSEcCtD
Isosorbide Mononitrate—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000808	0.000976	CcSEcCtD
Isosorbide Mononitrate—Urethral disorder—Methotrexate—lymphatic system cancer	0.000802	0.000969	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000798	0.000965	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Carmustine—lymphatic system cancer	0.000798	0.000964	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Vincristine—lymphatic system cancer	0.000792	0.000957	CcSEcCtD
Isosorbide Mononitrate—Rash—Carmustine—lymphatic system cancer	0.000791	0.000956	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Carmustine—lymphatic system cancer	0.000791	0.000955	CcSEcCtD
Isosorbide Mononitrate—Visual impairment—Methotrexate—lymphatic system cancer	0.000789	0.000953	CcSEcCtD
Isosorbide Mononitrate—Headache—Carmustine—lymphatic system cancer	0.000786	0.00095	CcSEcCtD
Isosorbide Mononitrate—Tinnitus—Methotrexate—lymphatic system cancer	0.000763	0.000922	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Vincristine—lymphatic system cancer	0.000762	0.00092	CcSEcCtD
Isosorbide Mononitrate—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000759	0.000918	CcSEcCtD
Isosorbide Mononitrate—Rash—Vincristine—lymphatic system cancer	0.000755	0.000913	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Vincristine—lymphatic system cancer	0.000755	0.000912	CcSEcCtD
Isosorbide Mononitrate—Headache—Vincristine—lymphatic system cancer	0.000751	0.000907	CcSEcCtD
Isosorbide Mononitrate—Nausea—Carmustine—lymphatic system cancer	0.000745	0.000901	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Mitoxantrone—lymphatic system cancer	0.000742	0.000896	CcSEcCtD
Isosorbide Mononitrate—Rash—Mitoxantrone—lymphatic system cancer	0.000736	0.000889	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000735	0.000888	CcSEcCtD
Isosorbide Mononitrate—Chills—Methotrexate—lymphatic system cancer	0.000734	0.000887	CcSEcCtD
Isosorbide Mononitrate—Headache—Mitoxantrone—lymphatic system cancer	0.000731	0.000883	CcSEcCtD
Isosorbide Mononitrate—Mental disorder—Methotrexate—lymphatic system cancer	0.000717	0.000866	CcSEcCtD
Isosorbide Mononitrate—Malnutrition—Methotrexate—lymphatic system cancer	0.000712	0.000861	CcSEcCtD
Isosorbide Mononitrate—Nausea—Vincristine—lymphatic system cancer	0.000712	0.00086	CcSEcCtD
Isosorbide Mononitrate—Dysgeusia—Methotrexate—lymphatic system cancer	0.000698	0.000843	CcSEcCtD
Isosorbide Mononitrate—Nausea—Mitoxantrone—lymphatic system cancer	0.000693	0.000837	CcSEcCtD
Isosorbide Mononitrate—Back pain—Methotrexate—lymphatic system cancer	0.000689	0.000833	CcSEcCtD
Isosorbide Mononitrate—Vision blurred—Methotrexate—lymphatic system cancer	0.000671	0.000811	CcSEcCtD
Isosorbide Mononitrate—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000661	0.000799	CcSEcCtD
Isosorbide Mononitrate—Anaemia—Methotrexate—lymphatic system cancer	0.000658	0.000796	CcSEcCtD
Isosorbide Mononitrate—Malaise—Methotrexate—lymphatic system cancer	0.000642	0.000776	CcSEcCtD
Isosorbide Mononitrate—Vertigo—Methotrexate—lymphatic system cancer	0.00064	0.000773	CcSEcCtD
Isosorbide Mononitrate—Leukopenia—Methotrexate—lymphatic system cancer	0.000638	0.00077	CcSEcCtD
Isosorbide Mononitrate—Cough—Methotrexate—lymphatic system cancer	0.000622	0.000751	CcSEcCtD
Isosorbide Mononitrate—Myalgia—Methotrexate—lymphatic system cancer	0.000606	0.000733	CcSEcCtD
Isosorbide Mononitrate—Arthralgia—Methotrexate—lymphatic system cancer	0.000606	0.000733	CcSEcCtD
Isosorbide Mononitrate—Chest pain—Methotrexate—lymphatic system cancer	0.000606	0.000733	CcSEcCtD
Isosorbide Mononitrate—Discomfort—Methotrexate—lymphatic system cancer	0.000599	0.000724	CcSEcCtD
Isosorbide Mononitrate—Confusional state—Methotrexate—lymphatic system cancer	0.000586	0.000708	CcSEcCtD
Isosorbide Mononitrate—Infection—Methotrexate—lymphatic system cancer	0.000578	0.000698	CcSEcCtD
Isosorbide Mononitrate—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00057	0.000689	CcSEcCtD
Isosorbide Mononitrate—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000569	0.000688	CcSEcCtD
Isosorbide Mononitrate—Skin disorder—Methotrexate—lymphatic system cancer	0.000565	0.000682	CcSEcCtD
Isosorbide Mononitrate—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000562	0.000679	CcSEcCtD
Isosorbide Mononitrate—Anorexia—Methotrexate—lymphatic system cancer	0.000554	0.00067	CcSEcCtD
Isosorbide Mononitrate—Hypotension—Methotrexate—lymphatic system cancer	0.000543	0.000656	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00053	0.00064	CcSEcCtD
Isosorbide Mononitrate—Insomnia—Methotrexate—lymphatic system cancer	0.000526	0.000635	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Methotrexate—lymphatic system cancer	0.000522	0.000631	CcSEcCtD
Isosorbide Mononitrate—Dyspnoea—Methotrexate—lymphatic system cancer	0.000518	0.000626	CcSEcCtD
Isosorbide Mononitrate—Somnolence—Methotrexate—lymphatic system cancer	0.000517	0.000624	CcSEcCtD
Isosorbide Mononitrate—Dyspepsia—Methotrexate—lymphatic system cancer	0.000512	0.000618	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Methotrexate—lymphatic system cancer	0.000505	0.000611	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000502	0.000606	CcSEcCtD
Isosorbide Mononitrate—Fatigue—Methotrexate—lymphatic system cancer	0.000501	0.000606	CcSEcCtD
Isosorbide Mononitrate—Pain—Methotrexate—lymphatic system cancer	0.000497	0.000601	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000479	0.000579	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000475	0.000574	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Methotrexate—lymphatic system cancer	0.00046	0.000555	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Methotrexate—lymphatic system cancer	0.00046	0.000555	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000428	0.000518	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Methotrexate—lymphatic system cancer	0.000417	0.000504	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Methotrexate—lymphatic system cancer	0.000411	0.000497	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Methotrexate—lymphatic system cancer	0.000398	0.000481	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Methotrexate—lymphatic system cancer	0.000384	0.000465	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Methotrexate—lymphatic system cancer	0.00037	0.000447	CcSEcCtD
Isosorbide Mononitrate—Rash—Methotrexate—lymphatic system cancer	0.000367	0.000443	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Methotrexate—lymphatic system cancer	0.000366	0.000443	CcSEcCtD
Isosorbide Mononitrate—Headache—Methotrexate—lymphatic system cancer	0.000364	0.00044	CcSEcCtD
Isosorbide Mononitrate—Nausea—Methotrexate—lymphatic system cancer	0.000345	0.000417	CcSEcCtD
